JW Therapeutics to raise $20 million in share placement at 3% discount
Cell immunotherapy biotechnology company JW (Cayman) Therapeutics Co. Ltd. (2126.HK) said on Sunday it plans to issue 61.19 million new shares to two institutional investors at a subscription price of…
Traditional medicine maker Neautus rises 72% in Hong Kong trading debut
Shares of Sichuan Neautus Traditional Chinese Medicine Co. Ltd. (2206.HK) jumped in their Hong Kong trading debut on Wednesday, as retail investors clamored to buy into China’s largest private producer…
Legend Biotech shares tumble as Carvykti outlook overshadows profit
Cancer treatment developer Legend Biotech Corp. (LEGN.US) reported on Tuesday that its third-quarter revenue rose 32% year-on-year to $359.5 million, while its net income reached $51.7 million, reversing a $39.6…
Neautus launches Hong Kong IPO at up to HK$3.3 billion valuation
Sichuan Neautus Traditional Chinese Medicine Co. Ltd. (2206.HK) launched its Hong Kong IPO on Oct. 30, targeting a valuation of up to HK$3.3 billion ($423 million), as it seeks to…
Kangning Hospital’s outpatient visits plunge 20% in third quarter
Medical facility operator Wenzhou Kangning Hospital Co. Ltd. (2120.HK) on Tuesday reported its outpatient visits fell 19.6% year-over-year to 142,692 in the third quarter, while average outpatient spending per visit…
111 Inc. receives management-led privatization offer
Drug seller 111 Inc. (YI.US) on Thursday announced its revenue contracted and its loss widened in the second quarter as it transitions to a new asset-light business model. The same…
Legend Biotech names new CEO
Cancer treatment maker Legend Biotech Corp. (LEGN.US) announced its appointment of a new CEO on Tuesday, a month and a half after the sudden departure of its longtime chief executive…